307 related articles for article (PubMed ID: 10330425)
1. Resistance to type 1 diabetes induction in 12-lipoxygenase knockout mice.
Bleich D; Chen S; Zipser B; Sun D; Funk CD; Nadler JL
J Clin Invest; 1999 May; 103(10):1431-6. PubMed ID: 10330425
[TBL] [Abstract][Full Text] [Related]
2. Interleukin-18 mRNA, but not interleukin-18 receptor mRNA, is constitutively expressed in islet beta-cells and up-regulated by interferon-gamma.
Hong TP; Andersen NA; Nielsen K; Karlsen AE; Fantuzzi G; Eizirik DL; Dinarello CA; Mandrup-Poulsen T
Eur Cytokine Netw; 2000 Jun; 11(2):193-205. PubMed ID: 10903798
[TBL] [Abstract][Full Text] [Related]
3. Induction of cyclooxygenase-2 gene in pancreatic beta-cells by 12-lipoxygenase pathway product 12-hydroxyeicosatetraenoic acid.
Han X; Chen S; Sun Y; Nadler JL; Bleich D
Mol Endocrinol; 2002 Sep; 16(9):2145-54. PubMed ID: 12198250
[TBL] [Abstract][Full Text] [Related]
4. Nitric oxide mediates cytokine-induced inhibition of insulin secretion by human islets of Langerhans.
Corbett JA; Sweetland MA; Wang JL; Lancaster JR; McDaniel ML
Proc Natl Acad Sci U S A; 1993 Mar; 90(5):1731-5. PubMed ID: 8383325
[TBL] [Abstract][Full Text] [Related]
5. IL-1 produced and released endogenously within human islets inhibits beta cell function.
Arnush M; Heitmeier MR; Scarim AL; Marino MH; Manning PT; Corbett JA
J Clin Invest; 1998 Aug; 102(3):516-26. PubMed ID: 9691088
[TBL] [Abstract][Full Text] [Related]
6. Activation of 12-lipoxygenase in proinflammatory cytokine-mediated beta cell toxicity.
Chen M; Yang ZD; Smith KM; Carter JD; Nadler JL
Diabetologia; 2005 Mar; 48(3):486-95. PubMed ID: 15729574
[TBL] [Abstract][Full Text] [Related]
7. Interleukin-1 plus gamma-interferon-induced pancreatic beta-cell dysfunction is mediated by beta-cell nitric oxide production.
Thomas HE; Darwiche R; Corbett JA; Kay TW
Diabetes; 2002 Feb; 51(2):311-6. PubMed ID: 11812737
[TBL] [Abstract][Full Text] [Related]
8. IL-1beta, IFN-gamma and TNF-alpha increase vulnerability of pancreatic beta cells to autoimmune destruction.
Wachlin G; Augstein P; Schröder D; Kuttler B; Klöting I; Heinke P; Schmidt S
J Autoimmun; 2003 Jun; 20(4):303-12. PubMed ID: 12791316
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of 1400 W, a novel inhibitor of inducible nitric oxide synthase, in preventing interleukin-1beta-induced suppression of pancreatic islet function in vitro and multiple low-dose streptozotocin-induced diabetes in vivo.
Rydgren T; Sandler S
Eur J Endocrinol; 2002 Oct; 147(4):543-51. PubMed ID: 12370118
[TBL] [Abstract][Full Text] [Related]
10. Interferon regulatory factor-1 down-regulates cytokine-induced IP-10 expression in pancreatic islets.
Baker MS; Chen X; Rotramel AR; Nelson JJ; Kaufman DB
Surgery; 2003 Aug; 134(2):134-41. PubMed ID: 12947309
[TBL] [Abstract][Full Text] [Related]
11. Cytokine-induced inhibition of insulin release from mouse pancreatic beta-cells deficient in inducible nitric oxide synthase.
Andersson AK; Flodström M; Sandler S
Biochem Biophys Res Commun; 2001 Feb; 281(2):396-403. PubMed ID: 11181061
[TBL] [Abstract][Full Text] [Related]
12. S-methyl-L-thiocitrulline counteracts interleukin 1 beta induced suppression of pancreatic islet function in vitro, but does not protect against multiple low-dose streptozotocin-induced diabetes in vivo.
Sternesjö J; Welsh N; Sandler S
Cytokine; 1997 May; 9(5):352-9. PubMed ID: 9195135
[TBL] [Abstract][Full Text] [Related]
13. Deletion of 12/15-lipoxygenase alters macrophage and islet function in NOD-Alox15(null) mice, leading to protection against type 1 diabetes development.
Green-Mitchell SM; Tersey SA; Cole BK; Ma K; Kuhn NS; Cunningham TD; Maybee NA; Chakrabarti SK; McDuffie M; Taylor-Fishwick DA; Mirmira RG; Nadler JL; Morris MA
PLoS One; 2013; 8(2):e56763. PubMed ID: 23437231
[TBL] [Abstract][Full Text] [Related]
14. The role of interferon regulatory factor-1 in cytokine-induced mRNA expression and cell death in murine pancreatic beta-cells.
Pavlovic D; Chen MC; Gysemans CA; Mathieu C; Eizirik DL
Eur Cytokine Netw; 1999 Sep; 10(3):403-12. PubMed ID: 10477397
[TBL] [Abstract][Full Text] [Related]
15. Insulin-like growth factors prevent cytokine-mediated cell death in isolated islets of Langerhans from pre-diabetic non-obese diabetic mice.
Hill DJ; Petrik J; Arany E; McDonald TJ; Delovitch TL
J Endocrinol; 1999 Apr; 161(1):153-65. PubMed ID: 10194539
[TBL] [Abstract][Full Text] [Related]
16. Cytokines suppress human islet function irrespective of their effects on nitric oxide generation.
Eizirik DL; Sandler S; Welsh N; Cetkovic-Cvrlje M; Nieman A; Geller DA; Pipeleers DG; Bendtzen K; Hellerström C
J Clin Invest; 1994 May; 93(5):1968-74. PubMed ID: 7514190
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of poly (ADP-ribose) synthetase by gene disruption or inhibition with 5-iodo-6-amino-1,2-benzopyrone protects mice from multiple-low-dose-streptozotocin-induced diabetes.
Mabley JG; Suarez-Pinzon WL; Haskó G; Salzman AL; Rabinovitch A; Kun E; Szabó C
Br J Pharmacol; 2001 Jul; 133(6):909-19. PubMed ID: 11454665
[TBL] [Abstract][Full Text] [Related]
18. Inducible nitric oxide synthase (iNOS) in pancreatic islets of nonobese diabetic mice: identification of iNOS- expressing cells and relationships to cytokines expressed in the islets.
Rabinovitch A; Suarez-Pinzon WL; Sorensen O; Bleackley RC
Endocrinology; 1996 May; 137(5):2093-9. PubMed ID: 8612552
[TBL] [Abstract][Full Text] [Related]
19. Potential role of resident islet macrophage activation in the initiation of autoimmune diabetes.
Arnush M; Scarim AL; Heitmeier MR; Kelly CB; Corbett JA
J Immunol; 1998 Mar; 160(6):2684-91. PubMed ID: 9510167
[TBL] [Abstract][Full Text] [Related]
20. TNF-alpha and IFN-gamma potentiate the deleterious effects of IL-1 beta on mouse pancreatic islets mainly via generation of nitric oxide.
Cetkovic-Cvrlje M; Eizirik DL
Cytokine; 1994 Jul; 6(4):399-406. PubMed ID: 7948748
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
